Rocket Pharmaceuticals (RCKT) Total Non-Current Liabilities (2014 - 2026)
Rocket Pharmaceuticals' Total Non-Current Liabilities was $53.14 million in Q2 2026, down 19.1% from $65.71 million a year earlier but up 14.8% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at Rocket Pharmaceuticals came in at $52.17 million, down 17.6% from FY2024.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of -9.8% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $63.33 million in FY2024 (-10.6%), $70.83 million in FY2023 (+19.0%), $59.53 million in FY2022 (+41.0%) and $42.22 million in FY2021 (-51.6%).
- Quarterly Total Non-Current Liabilities has moved between $42.22 million (Q4 2021) and $70.83 million (Q4 2023) over five years.
- Compared with a year earlier, Total Non-Current Liabilities has declined for four straight quarters, with an average decline of 7.3% over the last eight quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q4 2022 (growth of 41.0%); the worst was Q1 2022 (a decline of 55.9%).
- Per Business Quant data, RCKT's Total Non-Current Liabilities in the three quarters before Q2 2026 was $46.31 million (Q1 2026), $52.17 million (Q4 2025) and $53.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Rocket Pharmaceuticals | 288.09 Mn | 288.09 Mn | - | 53.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.14 Mn |
| Mar 31, 2026 | 46.31 Mn |
| Dec 31, 2025 | 52.17 Mn |
| Sep 30, 2025 | 53.30 Mn |
| Jun 30, 2025 | 65.71 Mn |
| Mar 31, 2025 | 57.79 Mn |
| Dec 31, 2024 | 63.33 Mn |
| Sep 30, 2024 | 62.78 Mn |
| Jun 30, 2024 | 60.53 Mn |
| Mar 31, 2024 | 56.03 Mn |
| Dec 31, 2023 | 70.83 Mn |
| Sep 30, 2023 | 55.81 Mn |
| Jun 30, 2023 | 56.74 Mn |
| Mar 31, 2023 | 54.01 Mn |
| Dec 31, 2022 | 59.53 Mn |
| Sep 30, 2022 | 49.92 Mn |
| Jun 30, 2022 | 44.11 Mn |
| Mar 31, 2022 | 42.47 Mn |
| Dec 31, 2021 | 42.22 Mn |
| Sep 30, 2021 | 44.49 Mn |
API Access
Rocket Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();